Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis

被引:8
|
作者
Konen, Franz Felix [1 ]
Hannich, Malte Johannes [2 ]
Schwenkenbecher, Philipp [1 ]
Grothe, Matthias [3 ]
Gag, Konrad [3 ]
Jendretzky, Konstantin Fritz [1 ]
Gingele, Stefan [1 ]
Suhs, Kurt-Wolfram [1 ]
Witte, Torsten [4 ]
Skripuletz, Thomas [1 ]
Suesse, Marie [3 ]
机构
[1] Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany
[2] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany
[3] Univ Med Greifswald, Dept Neurol, D-17475 Greifswald, Germany
[4] Hannover Med Sch, Dept Rheumatol & Immunol, D-30625 Hannover, Germany
关键词
multiple sclerosis; free light chains kappa; cerebrospinal fluid; humoral immune response; immunoglobulins; oligoclonal bands; MRZ reaction; early onset MS; late onset MS; progressive MS; FREE LIGHT-CHAINS; MRZ REACTION; QUANTIFICATION; IMPAIRMENT; ANTIBODIES; PATTERNS; PROGRESS; BLOOD; SERUM;
D O I
10.3390/biomedicines10071629
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The intrathecal humoral response is the characteristic diagnostic finding in the cerebrospinal fluid (CSF) analysis of patients with multiple sclerosis (MS). Although the average age of MS patients increases, little is known about the sensitivity of diagnostic markers in elderly MS patients. Methods: In this retrospective two-center study, intrathecal free light chains kappa fraction (FLCk IF) and oligoclonal bands (OCB) were studied in a large cohort of patients with early and late onset relapsing (RMS) and progressive (PMS) MS. Furthermore, the humoral immune profile in CSF was analyzed, including the polyspecific intrathecal immune response measured as the MRZ reaction. Results: While the frequency of CSF-specific OCB did not differ between early and late onset RMS and PMS, the sensitivity of positive FLCk IF and absolute FLCk IF values were lower in PMS. The positivity of the MRZ reaction was equally frequent in early and late onset RMS and PMS. PMS patients had higher local IgA concentrations than RMS patients (p = 0.0123). Conclusions: OCB are slightly superior to FLCk IF in progressive MS in terms of sensitivity for detecting intrathecal immunoglobulin synthesis. The MRZ reaction, as the most specific parameter for MS, is also applicable in patients with late onset and progressive MS.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Cerebrospinal fluid diagnostics in multiple sclerosis
    Ruprecht, K.
    Tumani, H.
    NERVENARZT, 2016, 87 (12): : 1282 - 1287
  • [2] Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis
    Harris, Violaine K.
    Donelan, Nicola
    Yan, Qi Jiang
    Clark, Kristi
    Touray, Amir
    Rammal, Mustapha
    Sadiq, Saud A.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 1462 - 1472
  • [3] Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
    Lo Sasso, Bruna
    Agnello, Luisa
    Bivona, Giulia
    Bellia, Chiara
    Ciaccio, Marcello
    MEDICINA-LITHUANIA, 2019, 55 (06):
  • [4] Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis
    Madeddu, Roberto
    Farace, Cristiano
    Tolu, Paola
    Solinas, Giuliana
    Asara, Yolande
    Sotgiu, Maria Alessandra
    Delogu, Lucia Gemma
    Carlos Prados, Jose
    Sotgiu, Stefano
    Montella, Andrea
    NEUROLOGICAL SCIENCES, 2013, 34 (02) : 181 - 186
  • [5] Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis
    Roberto Madeddu
    Cristiano Farace
    Paola Tolu
    Giuliana Solinas
    Yolande Asara
    Maria Alessandra Sotgiu
    Lucia Gemma Delogu
    Jose Carlos Prados
    Stefano Sotgiu
    Andrea Montella
    Neurological Sciences, 2013, 34 : 181 - 186
  • [6] Cerebrospinal Fluid Testing for Multiple Sclerosis
    Goldsmith, Joshua F.
    Herskovits, A. Zara
    CLINICS IN LABORATORY MEDICINE, 2020, 40 (03) : 369 - +
  • [7] Cerebrospinal fluid in multiple sclerosis
    Rammohan, Kottil W.
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2009, 12 (04) : 246 - 253
  • [8] An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis
    Gastaldi, Matteo
    Zardini, Elisabetta
    Franciotta, Diego
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (01) : 31 - 46
  • [9] Distinct clinical, imaging, and cerebrospinal fluid profiles in people with late-onset multiple sclerosis
    Steinegger, Lukas
    Kana, Veronika
    Nierobisch, Nathalie
    Elshahabi, Adham
    Weller, Michael
    Herwerth, Marina
    Roth, Patrick
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 97
  • [10] BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset
    Puthenparampil, M.
    Miante, S.
    Federle, L.
    Zanetta, C.
    Toffanin, E.
    Ruggero, S.
    Rinaldi, F.
    Gallo, P.
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 297 : 63 - 67